News
Reuters on MSN47m
AstraZeneca to invest $50 bln in US as pharma tariffs loom
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results